Brain causality alterations in major depressive disorder treatment
IntroductionMajor depressive disorder (MDD) remains a leading cause of disability worldwide, with limited objective biomarkers to guide treatment selection and monitor early therapeutic effects. This study examines whether pharmacological and neurostimulation treatments produce distinct alterations...
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Frontiers Media S.A.
2026-01-01
|
| Schriftenreihe: | Frontiers in Psychiatry |
| Schlagworte: | |
| Online-Zugang: | https://www.frontiersin.org/articles/10.3389/fpsyt.2025.1718216/full |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|